2025-01-26 - Analysis Report
## Johnson & Johnson (JNJ) Stock Analysis Report

**1. Performance vs. S&P 500 (VOO):**

Johnson & Johnson is a multinational medical devices, pharmaceutical, and consumer packaged goods company.  Over the observed period, JNJ's cumulative return (25.31%) significantly underperformed the S&P 500's cumulative return (52.12%). The difference is -26.8%, placing it in the 3rd percentile of historical performance relative to the S&P 500 based on the provided data's range.  This indicates JNJ's underperformance compared to the broader market.


The provided CAGR data shows inconsistent performance over different periods, ranging from positive growth to significant negative growth.  The high Beta values (around 1.0) suggest JNJ's price movements are highly correlated with the overall market.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2020-2022  | 17.0% | 6.9% | 19.0% | 1.0 | 400.1 |
| 2021-2023  | -11.0% | 6.9% | -19.0% | 1.0 | 365.8 |
| 2022-2024  | -25.0% | 8.0% | -49.0% | 1.0 | 348.2 |
| 2023-2025  | -13.0% | 8.0% | -56.0% | 1.0 | 353.5 |

**2. Recent Price Movement:**

* **Closing Price:** $146.82
* **5-Day Moving Average:** $146.78
* **20-Day Moving Average:** $145.14
* **60-Day Moving Average:** $149.80

The price is slightly above the 5-day moving average, suggesting recent stability. However, it is below both the 20-day and 60-day moving averages, indicating a downward trend over the medium and long term.  The recent price change ($0.12 increase) is minimal and doesn't suggest a significant upward or downward shift.


**3. Technical Indicators & Expected Return:**

* **RSI:** 57.20 (Slightly above neutral; neither overbought nor oversold)
* **PPO:** 0.3992 (Positive, suggesting bullish momentum)
* **20-Day Relative Divergence:** -5.9% (Short-term bearish trend)
* **Expected Return:** 758.3% (This exceptionally high figure requires further investigation and clarification on its calculation methodology and underlying assumptions. A 758.3% return over two years is extraordinarily high and unrealistic without specific supporting information).

**4. Recent Earnings Analysis:**

The earnings data shows some volatility in EPS and relatively stable revenue.  The significant drop in EPS from Q3 2023 to Q4 2023 warrants further investigation into the underlying causes.


| Date       | EPS   | Revenue      |
|------------|-------|---------------|
| 2024-10-23 | $1.12 | $22.47 B     |
| 2024-07-25 | $1.95 | $22.45 B     |
| 2024-05-01 | $1.35 | $21.38 B     |
| 2024-02-16 | $1.68 | $21.39 B     |
| 2023-10-27 | $10.32 | $21.35 B     |


**5. Financial Information:**

Revenue remained relatively consistent, while profit margins have fluctuated around 69%.  Equity and ROE values show volatility, with a particularly high ROE in Q3 2023. This high ROE requires further investigation and context.


Revenue and Profitability:

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-09-30 | $22.47B | 69.01% |
| 2024-06-30 | $22.45B | 69.40% |
| 2024-03-31 | $21.38B | 69.55% |
| 2023-12-31 | $21.39B | 68.23% |
| 2023-09-30 | $21.35B | 69.06% |

Capital and Profitability:

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-09-30 | $70.16B | 3.84% |
| 2024-06-30 | $71.54B | 6.55% |
| 2024-03-31 | $70.02B | 4.65% |
| 2023-12-31 | $68.77B | 5.89% |
| 2023-09-30 | $71.23B | 36.54% |


**7. Overall Analysis:**

JNJ has underperformed the S&P 500 over the given period, showing a negative alpha. While the recent price action shows some stability, the medium-to-long-term trend is slightly bearish. Earnings data exhibits volatility, particularly in EPS.  Financial information indicates relatively stable revenue and profit margins but significant fluctuations in ROE, requiring deeper analysis.  The extremely high projected return needs justification.  Further investigation is necessary to understand the drivers of EPS volatility and the exceptionally high projected return.  A more thorough fundamental analysis, considering factors like industry trends, competitive landscape, and future growth prospects, is required for a comprehensive evaluation.


**8. Disclaimer:** This report is for informational purposes only and does not constitute financial advice.  Investing in the stock market involves risk, and past performance is not indicative of future results. Conduct thorough research and seek professional advice before making any investment decisions.
